(Q39493756)

12 September 2017

1 reference

title

The biology, pathophysiology and control of eicosanoids in inflammation (English)

1 reference

12 September 2017

0 references

1 reference

Higgins AJ

1

1 reference

12 September 2017

publication date

1 March 1985

1 reference

Journal of Veterinary Pharmacology and Therapeutics

12 September 2017

published in

1 reference

12 September 2017

volume

8

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

1-18

1 reference

Prostaglandin D2 is the prevailing prostaglandin in the acute inflammatory exudate of urate arthritis in the chicken

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Psoriasis and leukotriene B4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Leukotriene B4: a mediator of vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

How aspirin might work: a pharmacokinetic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Protection by acetylsalicylic acid and other agents in experimental acute interstitial pneumonia of calves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Pyrogen fever and prostaglandin-like activity in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Release of noradrenaline from sympathetic endings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

The hyperalgesic effects of prostacyclin and prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

The importance of phospholipase-A2 in prostaglandin biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Inhibition of abortion and fetal death produced by endotoxin or prostaglandin F2alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

A bioassay technique for prostaglandin-like activity in equine inflammatory exudate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

A new approach to anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

The Biology and Pathology of Oxygen Radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Effects on body temperature of prostaglandins of the A, E and F series on injection into the third ventricle of unanaesthetized cats and rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Corneal infections after cortisone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Structure of slow-reacting substance of anaphylaxis from guinea-pig lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Leukotriene C: a slow-reacting substance from murine mastocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Isolation and properties of intermediates in prostaglandin biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Chemokinetic activity of arachidonic acid lipoxygenase products on leuocyctes of different species

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

The release of prostaglandins from lung and other tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Introduction of a nomenclature: Leukotrienes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Prostaglandins and thromboxanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Leukotrienes and slow reacting substance of anaphylaxis (SRS-A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Pharmacological activity of leukotrienes A4, B4, C4 and D4 on selected guinea-pig, rat, rabbit and human smooth muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Territoriality in the white rhinoceros (Ceratotherium simum) Burchell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Phenylbutazone toxicity in ponies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Species difference in increased vascular permeability by synthetic leukotriene C4 and D4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

The mode of action of aspirin and similar compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Selective Cyclic Nucleotide Phosphodiesterase Inhibitors as Potential Therapeutic Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Mechanisms underlying gastric mucosal damage induced by indomethacin and bile-salts, and the actions of prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1α on the rat gastric mucosa in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

The National Research Centre for Disaster Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Prostaglandins: Their Disappearance from and Release into the Circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Macrophages synthesise and release prostaglandins in response to inflammatory stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Role of prostaglandin endoperoxide PGG2 in inflammatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Control of vascular permeability by polymorphonuclear leukocytes in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1985.TB00919.X

10.1111/J.1365-2885.1985.TB00919.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference